Aurobindo Pharma Gets US Regulator's Nod for Oral Contraceptive Tablets

New Delhi: Drug firm Aurobindo Pharma has received final approval from the US Food and Drug Administration (FDA) to manufacture and market its oral contraceptive Levonorgestrel tablets. "The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Levonorgestrel tablet, 1.5 mg," Aurobindo Pharma said in a statement. The approved abbreviated new drug application (ANDA) is generic v...